Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC20001 | p38α inhibitor 1 |
p38α inhibitor 1 is a p38α inhibitor extracted from patent WO 2008076265 A1.
More description
|
![]() |
DC20047 | PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 is a highly selective type II PDGFRα kinase inhibitor with IC50s of 132 nM and 6115 nM for PDGFRα and PDGFRβ, respectively.
More description
|
![]() |
DC20007 | P-gp inhibitor 1 |
P-gp inhibitor 1 is a novel inhibitor reversing P-glycoprotein-mediated multidrug resistance.
More description
|
![]() |
DC20090 | PI3K/mTOR Inhibitor-1 |
PI3K/mTOR Inhibitor-1 is a potent, orally bioavailable dual PI3K/mTOR inhibitor with IC50s of 20/376/204/46 nM and 186 nM for PI3Kα/PI3Kβ/PI3Kγ/PI3Kδ and mTOR, respectively. Antitumor activity.
More description
|
![]() |
DC20051 | Sauristolactam (Saurolactam) |
Sauristolactam, a natural aristolactam isolated from aerial portions of Saururus chinensis, has significant neuroprotective activity against glutamate-induced toxicity in primary cultured rat cortical cells. Sauristolactam also inhibits the receptor activ
More description
|
![]() |
DC9767 | SHR-1977 Featured |
SHR-1977 is a novel ROMK/hERG inhibitor, (ROMK IC50 = 44 nM, hERG IC50 = >100,000 nM)
More description
|
![]() |
DC20098 | SRPKIN-1 |
SRPKIN-1 is a covalent and irreversible SRPK1/2 inhibitor with IC50s of 35.6 and 98 nM, respectively. Anti-angiogenesis effect.
More description
|
![]() |
DC9794 | SU-10994 |
SU-10994 is a novel VEGFR inhibitor.
More description
|
![]() |
DC20117 | SW-163D-AcLysValCit-PABC-DMAE |
SW-163D-AcLysValCit-PABC-DMAE is a Drug-Linker Conjugates for ADC which consists of a natural bis-intercalator, SW-163D, conjugated via an AcLysValCitPABC-DMAE linker.
More description
|
![]() |
DC8880 | Orteronel (TAK-700) |
TAK-700 shows potent inhibitory activity against rat, monkey, and human steroid 17,20-lyase inhibitor with IC50 of 54 nM, 27 nM, and 38 nM, respectively.
More description
|
![]() |
DC20048 | TAK-828F |
TAK-828F is a potent, selective, and orally available retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonist (binding IC50=1.9 nM, reporter gene IC50=6.1 nM). TAK-828F shows excellent ROR isoforms selectivity (>5000-fold selectivity aga
More description
|
![]() |
DC20095 | Target Protein-binding moiety 6 hydrochloride |
Target Protein-binding moiety 6 hydrochloride is a compound that binds to BRD9, and used for inhibiting BRD9 activity, based on PROTAC.
More description
|
![]() |
DC10411 | TB500-2 |
TB500-2 is one of the TB500 metabolites. TB500 is a synthetic version of an active region of thymosin β4. TB500 is claimed to promote endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, collagen deposition and decreas
More description
|
![]() |
DC8652 | TGR-1202 hydrochloride(Umbralisib) |
TGR-1202 hydrochloride is an orally available, next generation PI3Kdelta inhibitor, inhibits PI3Kδ activity in enzyme and cell based assays with IC50 and EC50 values of 22.2 and 24.3 nM respectively.
More description
|
![]() |
DC23116 | (S)-GNE-140 |
The less active enantiomer of GNE-140, inhibits LDHA activity (18-fold less potent that (R)-GNE-140).
More description
|
![]() |
DC20099 | TM-25659 |
TM-25659 is a TAZ modulator. Anti-osteoporotic and anti-obesity activities.
More description
|
![]() |
DC20066 | Trk-IN-4 |
Trk-IN-4 is a potent pan-Trk inhibitor in cell-based assays with IC50s of 1.9 nM, 2.6 nM and 1.1 nM for TrkA, TrkB and TrkC, respectively. Anti-hyperalgesic effect.
More description
|
![]() |
DC20075 | Tubulin inhibitor 1 |
Tubulin inhibitor 1 is a tubulin inhibitor, occupying the colchicine binding site, inhibits tubulin polymerization. Tubulin inhibitor 1 shows potent anti-tumor activity, casues cellular mitotic arrest in the G2/M phase, and induces cellular apoptosis.
More description
|
![]() |
DC7687 | XMD-18-42 Featured |
XMD-18-42 is a NUAK1-sepcific inhibitor.
More description
|
![]() |
DC20049 | Y06036 |
Y06036 is a potent and selective BET inhibitor, which binds to the BRD4(1) bromodomain with Kd value of 82 nM. Antitumor activity.
More description
|
![]() |
DC20046 | Y06137 |
Y06137 is a potent and selective BET inhibitor, which binds to the BRD4(1) bromodomain with a Kd of 81 nM. Antitumor activity.
More description
|
![]() |
DC20196 | Z-LEHD-FMK;Caspase-9 Inhibitor |
Z-LEHD-FMK is a cell-permeable, competitive and irreversible inhibitor of enzyme caspase-9, which helps in cell survival.
More description
|
![]() |
DC9245 | LDE-225 HCl |
![]() |
|
DC26066 | BAY 61-3606 hydrochloride Featured |
BAY 61-3606 is a potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase with Ki of 7.5 nM, displays no inhibitory effect against Btk, Fyn, Itk, Lyn, and Src.
More description
|
![]() |
DC31420 | JPH203 dihydrochloride |
JPH203, also known as KYT-0353, is a potent and selective LAT1 selective ( L-type amino acid transporter 1) inhibitor. JPH203 can very potently inhibit l-leucine uptake. JPH203 inhibits YD-38 cell growth. JPH203 up-regulated the population of apoptotic Y
More description
|
![]() |
DC8511 | TG-46 Featured |
TG-46 is an inhibitor of JAK2, FLT3, RET, JAK3 with IC50 values of 6nM, 25nM, 17nM, 169nM respectively.
More description
|
![]() |
DC12391 | BL-AD008 Featured |
BL-AD008 (BL-AD 008) is a novel small molecule, dual-target activator targeting AMPK/ZIPK; demonstrates remarkable anti-proliferative activities toward cervical cancer cells and could induce apoptosis by death-receptor and mitochondrial pathways; also sho
More description
|
![]() |
DC23086 | Vandetanib hydrochloride |
A potent and selective VEGFR2 (KDR) inhibitor with IC50 of 40 nM.
More description
|
![]() |
DCZ-121 | Vitamin B6 |
>98%,Standard References
More description
|
![]() |
DCM-065 | 3-O-galloylmucic acid |
>98%,Standard References
More description
|
![]() |